Dr Dominique Monferrer, Medical Device Director at ASPHALION, participated on Monday this week as ASPHALION´s external expert guest in a workshop organized by PERMIT. The EU-funded PERMIT project aims to develop recommendations for robust and reproducible personalised medicine research.
The objective of PERMIT is to establish, with all relevant stakeholders and invited experts, recommendations ensuring the robustness of personalised medicine trials, which also requires validation of the stratification methods.
The workshop focused on the regulatory gaps that have been identified in the personalized medicine research pipeline so far. The meeting was an interactive discussion and was attended by diverse stakeholders, including representatives from EMA, national competent authorities and the European Commission, which provided a balanced and broad perspective.
For further information, you can contact us at: [email protected]
